(Press-News.org) DALLAS – May 19, 2011 – Ray Johnston's goal in three years is for his band to sell out at the 1,600-seat House of Blues in Dallas. In eight years, he wants to pack the 6,400-seat Verizon Theatre in Grand Prairie, and by 2030, to play to tens of thousands of fans at Cowboys Stadium in Arlington.
Mr. Johnston's unmentioned goal, though, is to live another year after battling leukemia for the past seven. Despite four relapses, the former Dallas Mavericks basketball player is enjoying life as a rising musician in The Ray Johnston Band.
Although he credits God for his recovery, Mr. Johnston also gives thanks to Dr. Robert Collins, director of the Bone Marrow Transplantation/Hematologic Malignancies Program at UT Southwestern Medical Center, and the experimental drug that has killed his rare, stubborn form of cancer called acute promyelocytic leukemia.
"It's got to be inspiring to Dr. Collins to see that I'm alive because I'm supposed to be done by now," Mr. Johnston said of his painful yet rewarding journey, which was chronicled last year in an HDNet series called "Ray Johnston Band: Road Diaries."
Today, Mr. Johnston's self-described "happy rock" Dallas band is working on its second CD and booking about 100 shows a year. "My primary goal is to keep playing," Mr. Johnston said.
Tamibarotene, the drug that's kept the 32-year-old musician alive, is a retinoid drug that induces cancer cells to differentiate into mature cells and eventually die. Available only in clinical trials in the U.S., tamibarotene was sought for Mr. Johnston under a compassionate use protocol since he did not qualify for those studies and other treatments had been exhausted. The drug, approved only in Japan for cancer treatment, is being developed domestically by CytRx.
"It's amazing that he's still doing so well," said Dr. Collins, professor of internal medicine and senior author of a report on this case published online April 11 in the Journal of Clinical Oncology. "This drug happens to be just right for him."
Mr. Johnston's treatment with tamibarotene, which is considered 10 times more potent than all-trans retinoic acid, another retinoid commonly used to treat this type of leukemia, began in December 2009. He took the drug twice daily for 56 days, followed by a two-week break. Since then, Mr. Johnston has been taking the drug 28 days on, 28 off.
On April 18, he returned to UT Southwestern for a positron emission tomography (PET) scan, which showed his cancer had not relapsed for the fifth time.
"The type of acute leukemia he has is very rare. It's usually curable with current therapies, but as it relapses it becomes more resistant and harder to treat," said Dr. Collins.
Gambling on life, and success as a musician, doesn't scare the Alabama native who once dreamed of a professional basketball career. But cancer ended his NBA stint, which began when he won a spot on the Dallas Mavericks summer league roster during a Hoop It Up tournament in 2004.
Mr. Johnston didn't even know he had leukemia until that August, when he injured his leg in a pick-up game. He was diagnosed with compartment syndrome, a condition in which pressure in the muscle builds to dangerous levels. Following surgery, doctors were unable to control bleeding. They soon discovered that Mr. Johnston's body was riddled with advanced leukemia.
His treatment included chemotherapy, surgery and a bone marrow transplant. Mr. Johnston's type of leukemia, which affects soft tissues rather than blood and bone marrow, represents just 5 percent to 8 percent of acute myelogenous leukemia, the most common form of the disease.
Discouraged by failing treatments and the thought of his first bone marrow transplant, he nearly gave up hope. In 2006, a recommendation from a friend led him to Dr. Collins and UT Southwestern.
"When you achieve a life milestone that you're not supposed to, when you hug it out, you can see and feel Dr. Collins drop a tear on your shoulder. That's life. That's real," said Mr. Johnston.
Reality for this cancer survivor also means getting serious about music. Mr. Johnston has a lot of work ahead after launching the six-member band in September 2009. Some of the band's performances raise money for The Ryan Gibson Foundation, a Dallas-based nonprofit dedicated to leukemia research.
One of the songs on the band's first CD, "Sweet Tooth," is Rise & Go, based on a verse in the Bible, Luke 17:19. Mr. Johnston said it sums up "my last seven years."
"Wake up and I go outside, I see my blue sky, I'm happy to be alive … I got a tough upper lip, but a bottom little broken heart. When I look into the sky, I see my Maker's eyes. That's when I know my Plan B for eternity is strong as gold, so I rise and go.
###
Visit www.utsouthwestern.org/cancer to learn more about UT Southwestern's clinical services in cancer.
This news release is available on our World Wide Web home page at
www.utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via email,
subscribe at www.utsouthwestern.edu/receivenews
END
Analysis of a 440-year-old document reveals new details about native population decline in the heartland of the Inca Empire following Spanish conquest in the 16th century.
According to the analysis, the native Andean population in the Yucay Valley of Peru showed a remarkable ability to bounce back in the short term from the disease, warfare, and famine that accompanied the initial Spanish invasion. However, it was the repetition of such disasters generation after generation, along with overly rigid colonial administration, that dramatically reduced the population over ...
Archaeologists have discovered a 12,000-year-old iron oxide mine in Chile that marks the oldest evidence of organized mining ever found in the Americas, according to a report in the June issue of Current Anthropology.
A team of researchers led by Diego Salazar of the Universidad de Chile found the 40-meter trench near the coastal town of Taltal in northern Chile. It was dug by the Huentelauquen people—the first settlers in the region—who used iron oxide as pigment for painted stone and bone instruments, and probably also for clothing and body paint, the researchers say. ...
TradingFloor.com, the home of Saxo Bank's trading commentary, financial research and analysis, has released a video discussing the first quarter earnings wrap and specifically what happened to margin pressure.
It seems margin pressure hardly emerged and that its effects (on the back of higher commodities), especially for consumer driven companies, will instead first kick in later in the year. The underlying momentum for stocks remains strong. Pro-cyclical companies, in particular, posted good results largely driven by emerging markets), and this was confirmed in their ...
Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this type of cancer.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder which causes the development of benign but often painful tumours in the skin and, in females, in the uterus. Between one in six and one in ten people affected by the disorder will go on to develop an aggressive form of kidney cancer called papillary renal cell cancer. The ...
Chronic lower back pain is a major problem for society – behind only headaches as the most common neurological ailment – and is frequently caused by degeneration of the intervertebral disc.
Researchers have worked for many years to find a way of repairing the wear and tear on the lower back.
Now, in results published in the journal Soft Matter, they have discovered how to permanently replace the workings of the invertebral disc.
It is estimated that back pain affects 80% of people at some point in their lives. In the United States it is the most common cause of job-related ...
Europcar, the UK's leading vehicle hire company, continues to bring travellers the best rates with the launch of Privilege, its new loyalty programme. Membership is free, allowing frequent hirers to benefit from tailor made discounts, including up to 30% off all leisure rentals.
Reflecting its understanding of the time pressures on travellers - especially independent business travellers - Privilege provides members with crucial time-saving benefits. It eliminates queuing and paperwork and guarantees reservations. Plus, as well as saving money on car hire, Privilege ...
Are the dark spots on a patient's skin malignant? In the future, doctors will be able to take a closer look at suspicious blemishes using a new microscope – with results in just a few fractions of a second. It examines to a resolution of five micrometers; it's also flat and lightweight, and it records images so quickly that the results are not blurred even if the doctor is holding the microscope in his or her hand. For results with comparable resolution values, a conventional microscope would either be restricted to a tiny field forced to scan the surface: conventional ...
"We believe our business practices are compliant with the law and are working to resolve this disagreement with the appropriate government agencies. Our companies give consumers the opportunity to buy a variety of products and services at significant savings. Our business is based on the loyalty and longevity of our customer relationships. For example, we are proud to report that a large percentage of our customers continued to use our products after twelve months of use - a tremendous achievement given the global competition in the Internet marketplace. This loyalty, ...
What effect does climate change have on our local forests? What types of trees will be suitable for which geographic location? And how great is the pollution level here? Forestry scientists are conducting „forest monitoring" procedures: They continuously record parameters such as soil humidity or pollutant penetration at permanently installed monitoring stations. The results of such examinations contribute to maintaining the ecological stability of the forests over the long term. The problem: Not only are the wired measuring devices complex to install and maintain, they ...
Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.
Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract causing abdominal pain, diarrhea, gastrointestinal bleeding and weight loss. Treatments for Crohn's disease are designed to reduce the inflammation but may be associated with rare but serious side effects, including infections and lymphoma. Research suggests that endorphins and enkephalins, part of the opioid system, have a role in the development or continuation of inflammation.
Naltrexone ...
